Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 9609  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  [PDF Not available] *
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 


  IN THIS Article
 ::  References

 Article Access Statistics
    Viewed10601    
    Printed212    
    Emailed22    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


   
Year : 1981  |  Volume : 27  |  Issue : 3  |  Page : 129-32

Trace elements in diabetes mellitus.







How to cite this article:
Retnam V J, Bhandarkar S D. Trace elements in diabetes mellitus. J Postgrad Med 1981;27:129


How to cite this URL:
Retnam V J, Bhandarkar S D. Trace elements in diabetes mellitus. J Postgrad Med [serial online] 1981 [cited 2019 Nov 17];27:129. Available from: http://www.jpgmonline.com/text.asp?1981/27/3/129/5642



Mineral elements constitute a minute part of the living tissues. Yet, they are important for the vital processes of life. They were difficult to measure in the past. Hence, they were mentioned as occurring in traces and thus originated the term "trace elements". This term has persisted though they can now be estimated with great accuracy.
The importance of the trace elements in living organisms was first shown over a century ago. Claude Bernard and McMunn (Quoted by Lamb et al[11]) demonstrated the existence of a number of trace-metal-containing enzymes (metalloenzymes) of importance to the structural and functional integrity of the living cells. Growing concern with environmental factors in human health over the last few years has aroused renewed interest in the trace elements. Abnormalities in their metabolism have been demonstrated in many human diseases. In particular, diabetes mellitus has been shown to be associated with abnormalities in the metabolism of zinc, chromium, magnesium and maganese.
Zinc
Scott and Fischer[22] first recognized the relationship between zinc and insulin. They found that whereas the normal human pancreas contained significant quantities of zinc, the diabetic pancreas contained very little. Later, the availability of histochemical techniques for the detection of zinc confirmed that zinc and insulin concentrations in the pancreas changed in the same direction in a variety of situations in humans.[18] Organic compounds which were capable of reducing the zinc content of the pancreas were found to be diabetogenic[9] in animal experiments.
Meltzer et al[14] appear to be the first to have studied the urinary excretion of trace elements in diabetes mellitus. As a group, diabetics excrete more zinc in the urine than non-diabetics.[10], [14], [17] The mean plasma, leucocyte and erythrocyte zinc levels are significantly lower in diabetics than in non-diabetics.[10] This has been challenged by other workers.[4], [8], [15] No correlation has been found between the plasma or urinary zinc levels on the one hand and the age at onset of diabetes, the patient's age or his weight, on the other.[14],[17]
Some families excrete more zinc in the urine than others.[17] Family studies suggest that zincuria could be under polygenic control.[17] Urinary zinc excretion appears to be controlled by alleles at a number of loci and diabetics might possess a different assortment of these alleles as compared to non-diabetics.[17]
The exact cause of hyperzincuria is not known. Disturbed metabolism of zinc metalloenzymes and abnormal binding of zinc to tissue proteins have been suggested as possible causes.[10] The low plasma zinc levels in diabetics suggest that the hyperzincuria is of renal origin. Renal tubular defect in handling zinc and glucose-induced, osmotic diuresis are other possibilities.
Chromium
The biological activity of chromium depends on its valency and the chemical form of the complex of which it is a part.[8] Glucose tolerance factor (GTF) is a trivalent form of chromium that has high biological activity. GTF is a low molecular weight, soluble and dialysable organic compound.[8]This is required for optimal glucose utilisation by the cells.[8] That abnormalities in chromium metabolism exist in insulin dependent diabetics seems certain. Nanogram quantities of chromium are required in every insulin dependent system.[15] It has been suggested that by acting on the ribosomes chromium facilitates the insulinstimulated aminoacid incorporation into protein.[8], [15] The glucose intolerance seen as age advances has been attributed to chromium deficiency[3], [20], [25] If chromium administration can be shown to consistently correct the glucose intolerance of ageing, it might replace the use of the less physiological oral hypoglycemic agents in the treatment of this condition. Chromium is not a hypoglycemic agent in the usual pharmacological sense nor a substitute for insulin. It is a cofactor for the initiation of peripheral insulin action on the receptors on the cell membranes. [15], [27]
Insulin dependent diabetics excrete more chromium than the control subjects. However, there is no significant difference in the urinary excretion of chromium between maturity onset diabetics and normal controls[16] Chromium deficiency has also been held responsible for vascular complications associated with diabetes mellitus. Increased incidence of aortic plaques has been shown in chromium deficient animals.[19] Recent work has provided "Suggestive evidence for a relationship between certain body pools of chromium and carbohydrate metabolism in diabetes."[19] Lastly, hyperglycemia occurring during total parenteral hyperalimentation has been shown to be controlled and insulin requirements reduced by oral administration of microgramme quantities of chromium.'
Magnesium
Magnesium is known to be related to the carbohydrate and fat metabolism. Serum magnesium levels have been shown to be inversely related to the severity of diabetes.[25] Definite lowering of serum magnesium has been shown in patients on long term treatment with insulin and those recovering from diabetic ketoacidosis.[13] The cause of this hypomagnesemia is not known for certain but the following have been suggested as possible mechanisms: (1) increased loss of magnesium in urine due to the osmotic action of glycosuria;[13] and (2) depression of the net tubular reabsorption of magnesium due to hyperglycemia per se.[12]
Magnesium may also play a role in the release of insulin.[21] Magnesium depletion has an atherogenic potential.[23], [26] Hypomagnesemia has been postulated as a possible risk factor in the development and progression of diabetic retinopathy.[5], [13] Future research is called for to see if repletion of magnesium retards the progression of retinopathy. Patients with myocardial infarction had reversal of abnormal lipoprotein patterns to normal on administration of magnesium[2], [23] The Bantus have lower prevalence of I.H,D. and higher serum magnesium levels than the Europeans.[1]Thus, magnesium may well have a local protective effect on the vessel well.
Manganese
In experimental animals, pancreatectomy and diabetes have been correlated with decreased manganese levels in blood.[6] Further, manganese supplements have reversed the impaired glucose utilization induced by manganese deficiency in guinea pigs.[23]
It is thus seen that several abnormalities of trace metal metabolism have been demonstrated in diabetes mellitus, both human and experimental. Their pathogenetic implications and therapeutic applications must await further elucidation.

  ::   References Top

1.Bersohn, I. and Oelofse, P. J.: Correlation of serum-magnesium and serum cholesterol levels in South African Bantu and European subjects. Lancet, 1: 10201021, 1957.  Back to cited text no. 1    
2.Brown, D. F., McGandy, R. B., Guillie, E. and Doyle, J. T.: Magnesium-lipid relations in health and in patients with myocardial infarction. Lancet, 2: 933-965, 1958.  Back to cited text no. 2    
3.Cottfried, S. P., Pelz, K. S. and Clifford, R. C.: Carbohydrate metabolism in healthy old men and women over 70 years of age. Amer. J. Med. Sci., 242: 475-480, 1961.  Back to cited text no. 3    
4.Davies, I. J. T., Musa, M. and Dormandy, T. L.: Measurements of plasma zinc. Part I. In Health and Disease. J. Clin. Path., 21: 359-365,1968.  Back to cited text no. 4    
5.Editorial: Hypomagnesemia and diabetic retinopathy. Lancet, 1: 762, 1979.  Back to cited text no. 5    
6.Everson, G. J. and Shrader, R. E.: Abnormal glucose tolerance in manganese deficient guinea pigs. J. Nutr., 94: 89-94, 1968.  Back to cited text no. 6    
7.Freund, H., Atamian, A. and Fischer, J. E.: Chromium deficiency during total parenteral nutrition. J. Amer. Med. Assoc., 241: 496-498, 1979.  Back to cited text no. 7    
8.Hambidge, K. M.: Chromium nutrition in man. Amer. J. Clin. Nutr., 27: 505-515, 1974.  Back to cited text no. 8    
9.Kadota, I.: Studies on experimental diabetes mellitus as produced by organic reagents. J. Lab. & Clin. Med., 35: 568-591, 1950.  Back to cited text no. 9    
10.Kumar, S. and Rao, K. S. J.: Blood and urinary zinc levels in diabetes mellitus. Nut-r. Metab., 17: 231-235, 1974.  Back to cited text no. 10    
11.Lamb, C A., Bentley, O. G. and Beattle, J. M.: Trace elements. In, "Proceedings of the conference held at the Ohio Agricultural Experiment Station", Wooster, Ohio. Academic press-Inc. N.Y. & London, 1958, pp. 1-13.  Back to cited text no. 11    
12.Lemann, J. Jr., Lennon, E. J., Piering, W. R., Prien, E. I. Jr. and Ricanati, E. S.: Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. J. Lab. & Clin, Med., 75: 578-585, 1970.  Back to cited text no. 12    
13.McNair, P., Christiansen, C., Madsbad, S,. Lauritzen, E., Faber, O., Binder, C. and Transb, 1. J.: Hypomagnesemia-a risk factor in diabetic retinopathy. Diabetes, 2'7: 1075-1077, 1978.  Back to cited text no. 13    
14.Meltzer, L. E., Rutman, J., George, P., Rutman, R. and Kitchell, J. R.: Urinary excretion pattern of trace metals in diabetes mellitus. Amer. J. Med. Sci., 244: 282-289, 1974.  Back to cited text no. 14    
15.Mertz, W.: Chromium occurrence and function in biological systems. Physiol. Rev., 49: 163-169, 1969.  Back to cited text no. 15    
16.Mertz, W. and Cornatzer, W. E.: "Newer Trace Elements in Nutrition". Marcel Dekker Inc., New York. 1971, pp. 12A-153.   Back to cited text no. 16    
17.Pidduck, R. G., Wren, P. J. 3. and Evans, D. A. P.: Hyperzincuria of diabetes mellitus and possible genetical implications of this observation. Diabetes, 19: 240-247, 1970.  Back to cited text no. 17    
18.Prout, T. E., Asper, S. P. Jr., Lee, T. and Ray, B. L.: Zinc metabolism in patients with diabetes mellitus. Metabolism, 9: 109-117, 1950.  Back to cited text no. 18    
19.Rabinowitz, M. B., Levin, S. R. and Gonick, H. C.: Comparisons of chromium status in diabetic and normal men. Metabolism, 29: 355-364, 1980.  Back to cited text no. 19    
20.Schroeder, H. A. and Balassa, J. J.: Influence of chromium, cadmium and lead on rat aortic lipids and circulating cholesterol. Amer. J. Physiol., 209: 433-437,1965.   Back to cited text no. 20    
21.Schroeder, H. A., Balassa, J. J. and Tipton, I. A.: Abnormal trace metals in man. J. Chron. Dis., 15: 941-964, 1962.  Back to cited text no. 21    
22.Scott, D. A. and Fischer, A. M.: The insulin and the zinc content of normal and diabetic pancreas. J. Clin. Invest., 17: 725-728, 1938.  Back to cited text no. 22    
23.Seelig, M. S. and Heggtyeit, A.: Magnesium interrelationship in ischemic heart disease. Amer. J. Clin. Nutr., 27: 59-79, 1974.  Back to cited text no. 23    
24.Shrader, R. E. and Everson, G. J.: Pancreatic pathology in manganese deficient guinea pigs. J. Nutr., 94: 269-281, 1968.  Back to cited text no. 24    
25.Streter, D. H. P., Gerstein, M. M., Marmor, B. M. and Doisy, R. J.: Reduced glucose tolerance in elderly human subjects. Diabetes, 14: 579-583, 1965.  Back to cited text no. 25    
26.Stutzman, F. L. and Amatuzio, D. S.: blood serum magnesium in portal cirrhosis and diabetes mellitus. J. Lab. & Clin. Ned., 41: 215-219, 1953.  Back to cited text no. 26    
27.Toepfer, E. W., Roginski, E. E.. Polansky, M. M. and Mertz, W.: Present knowledge of the role of chromium. Federation Proe., 33: 2275-2280, 1974.  Back to cited text no. 27    

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow